CMS has released Medicare Part B drug average sales prices (ASPs) for the third quarter of 2010. According to CMS, average drug prices in the market generally remain stable compared to the previous quarter. Prices for the top Part B drugs decreases by 0.7%; when 3 drugs are excluded that had price drops of 20% or more due to the introduction of generics, there was a 1.1% overall price increase for the top Part B drugs.